Mardil, one of the newest companies based in Minnesota, wants to create a new innovative medical device that treats sloppy mitral valves short of doing open-heart surgery. It is trying to raise up to $12 million.
St. Jude Medical Inc. (NYSE:STJ) concluded its tender offer AGA Medical Holdings Inc. (NASDAQ:AGAM) and expects to close its $1.03 billion acquisition of the rival cardiovascular device maker today.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Shareholders of two companies set to be acquired are suing over the offers, alleging that the companies breached their fiduciary duties in agreeing to the buyouts. Investors in AGA Medical Holdings Inc. (NASDAQ:AGAM) sued in the Delaware Chancery Court over St. Jude Medical Inc.’s (NYSE:STJ) $1.3 billion offer for AGA, alleging that “the proposed transaction […]
The financial dealings for St. Jude Medical Inc.’s (NYSE:STJ) acquisition of AGA Medical Holdings Inc. (NASDAQ:AGAM) have begun. The St. Paul, Minnesota-based cardiac device maker commenced an exchange offer for all of the outstanding shares of AGA’s common stock. St. Jude announced the acquisition of AGA and its portfolio of transcatheter heart repair devices Oct. […]
Earnings reports are good ways to measure a company's financial performance. What they're less useful for is gauging a company's confidence. You know... Mojo. Swagger. Groove. And here's what I see: Medtronic Inc. (NYSE:MDT) always had it. Boston Scientific Corp. (NYSE:BSX) has lost it. And St. Jude Medical Inc. (NYSE: STJ) is feeling it.
When St. Jude Medical Inc. (NYSE:STJ) completes its $1.3 billion acquisition of AGA Medical Holdings Inc. (NASDAQ: AGAM) at the end of the year, it will end one of the briefest, most disappointing and weirdest tenures of a publicly traded company in Minnesota's recent history. Lost in the hoopla over St. Jude's all-cash, $20.80-a-share offer for AGA is that the announcement comes three days before AGA's one-year anniversary as a publicly traded stock.
St. Jude Medical Inc. (NYSE: STJ) said Monday it will acquire fellow Minnesota medical device maker AGA Medical Holdings Inc. (NASDAQ:AGAM) for $1.3 billion. Under terms of the all-cash agreement, St. Jude, based in Little Canada, will pay $20.80 for each share of AGA stock and assume $225 million in AGA debt. The company expects to close the deal by the end of the year.
Medical device companies probably aren't feeling the love from Wall Street, these days. The last two medical device companies from Minnesota to go public priced their IPOs far below what they expected. The malaise is not limited to Minnesota.
AGA Medical Holdings Inc. (NASDAQ: AGAM) filed a lawsuit against W.L. Gore & Associates alleging that the Newark, Del.-based company is infringing on a patent for its transcatheter occlusion device for heart defect treatment.
AGA Medical Holdings, Inc. (NSDQ:AGAM) posted a 10 percent increase in sales during the second quarter, helping the company reverse a $2 million loss from the same period last year. For the three month period ended on June 30 the Minneapolis, Minnesota-based company posted a $3.6 million profit on $53.7 million, compared to a $2 […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Cardiac and vascular device maker AGA Medical Holdings Inc. (NYSE: AGAM) has been awarded $2.6 million in damages by a German court in a patent-infringement case. AGA’s patent dispute with Germany-based Occlutech GmbH stretches back to 2006 and involves intravascular occlusion devices and the method of manufacturing those devices, according to a statement from Plymouth, […]
AGA Medical Inc. (NASDAQ: AGAM) has enrolled the first patient in a clinical trial of a cardiac device aimed at preventing strokes in patients with abnormal heartbeats. CEO John Barr called the first enrollment in the company’s Amplatzer Cardiac Plug trial “a significant milestone” for the company, according to a statement from AGA. The trial […]
Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and Exchange Commission. The orthopedics firm in Edina, Minn., which specializes in devices to treat injuries to extremities and small bones, is the third local medical device company […]
Shares of AGA Medical Holdings Inc. (NASDAQ: AGAM) fell more than 6 percent Tuesday after its top investor decided to divest a tenth of its holdings in the Plymouth, Minn.-based medical device maker. Welsh, Carson, Anderson & Stowe, a private equity firm and majority owner of AGA Medical, will disburse 2.4 million shares to its […]
Score the final round for device giant Medtronic Inc. in its three-year patent-infringement battle with AGA Medical Inc. over AGA’s Amplatzer cardiac plug. The two companies agreed to end the litigation with AGA paying Medtronic $35 million over four years. The final payment is due in 2014, according to a statement from AGA. In addition, […]
